Abstract:BACKGROUND: Previously, we demonstrated the therapeutic efficacy of a human papillomavirus (HPV) vaccine, including HPV16 E7 peptide and CpG oligodeoxynucleotides (CpG ODN), against small TC-1 grafted tumors. Here, we developed an HPV16 E7 peptide and CpG ODN vaccine delivered using liposomes modified with DC-targeting mannose, Lip E7/CpG, and determined its anti-tumor effects and influence on systemic immune responses and the tumor microenvironment (TME) in a mouse large TC-1 grafted tumor model.METHODS: L-alpha-phosphatidyl choline (SPC), cholesterol (CHOL), 1,2-distearoyl-<i>sn</i>-glycero-3-phosphoethanolamine-N-[methoxy (polyethylene glycol-2000)] (DSPE-PEG-2000), 1,2-dioleoyl-3-trimethylammonium-propane chloride salt (DOTAP) and Mannose-PEG-DSPE, loaded with HPV16 E7 peptide and CpG ODN, were used to construct the Lip E7/CpG vaccine. The anti-tumor effects and potential mechanism of Lip E7/CpG were assessed by assays of tumor growth inhibition, immune cells, in vivo cytotoxic T lymphocyte (CTL) responses and cytokines, chemokines, CD31, Ki67 and p53 expression in the TME. In addition, toxicity of Lip E7/CpG to major organs was evaluated.RESULTS: Lip E7/CpG had a diameter of 122.21±8.37 nm and remained stable at 4°C for 7 days. Co-delivery of HPV16 E7 peptide and CpG ODN by liposomes exerted potent anti-tumor effects in large (tumor volume ≥200mm<sup>3</sup>) TC-1 grafted tumor-bearing mice with inhibition rates of 80% and 78% relative to the control and Free E7/CpG groups, respectively. Vaccination significantly increased numbers of CD4+ and CD8+ T cells, and IFN-γ-producing cells in spleens and tumors and enhanced HPV-specific CTL responses, while reducing numbers of inhibitory cells including myeloid-derived suppressor cells and macrophages. Expression of cytokines and chemokines was altered and formation of tumor blood vessels was reduced in the Lip E7/CpG group, indicating possible modulation of the immunosuppressive TME to promote anti-tumor responses. Lip E7/CpG did not cause morphological changes in major organs.CONCLUSION: Lip E7/CpG induced anti-tumor effects by enhancing cellular immunity and improving tumor-associated immunosuppression. Mannose-modified liposomes are the promising vaccine delivery strategy for cancer immunotherapy.

Preliminary Study on Immune Mechanisms of Ph-Sensitive Transmembrane Peptide Modified Liposome Loaded with A-Galactosylceramides

Synthesis and Biological Activities of Amino Acids Functionalized Α-Galcer Analogues.

Anti-tumor Activities and Immune Regulation of Docosahexaenoic Acidphosphatidylcholine Liposomes in Mice Bearing S_(180)

Preliminary study on the mechanism of cartilage polysaccharide inducing H22 cell to engender immunogenicity

Uptake of Intraperitoneally Administrated Triple Helical Β-Glucan for Antitumor Activity in Murine Tumor Models

Optimization on Condition of Glycyrrhetinic Acid Liposome by RSM and the Research of Its Immunological Activity

pH-Sensitive branched β-glucan-modified liposomes for activation of antigen presenting cells and induction of antitumor immunity

A New Concept of Enhancing Immuno-Chemotherapeutic Effects Against B16F10 Tumor Via Systemic Administration by Taking Advantages of the Limitation of EPR Effect.

Sublingual injection of microparticles containing glycolipid ligands for NKT cells and subunit vaccines induces antibody responses in oral cavity.

Immunostimulatory Properties of Glycated Chitosan

The impact of size for liposomes modified with pH-responsive β-glucan derivatives on the initiation of cellular and humoral immune responses in murine models

Dextran derivative-based pH-sensitive liposomes for cancer immunotherapy

Potentiation of T Cell Function by a Marine Algae-Derived Sulfated Polymannuroguluronate: in Vitro Analysis of Novel Mechanisms.

Anti-tumor Activity of Angelica Polysaccharide-1Cii

Mannose-Modified Liposome Co-Delivery of Human Papillomavirus Type 16 E7 Peptide and CpG Oligodeoxynucleotide Adjuvant Enhances Antitumor Activity Against Established Large TC-1 Grafted Tumors in Mice

Glycated Chitosan As a New Non-Toxic Immunological Stimulant.

Macrophage membrane-coated Eucommia ulmoides polysaccharides-loaded PLGA nanoparticles as an effective antigen-targeted delivery system

Galactose-installed Photo-Crosslinked Ph-Sensitive Degradable Micelles for Active Targeting Chemotherapy of Hepatocellular Carcinoma in Mice.

Macrophage Immunomodulatory Activity of the Cationic Polymer Modified PLGA Nanoparticles Encapsulating Alhagi Honey Polysaccharide.

Simultaneous Enhancement of Cellular and Humoral Immunity by the Lymph Node-Targeted Cholesterolized TLR7 Agonist Liposomes

Construction of Chlorogenic Acid-Containing Liposomes with Prolonged Antitumor Immunity Based on T Cell Regulation